Overview

• The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care:
  • Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines.
  • Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices.
  • The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.

Eligibility

Eligibility Criteria:

• Receive care within the BJC Health System
• Have had at least one primary care physician appointment in the calendar year of PSA screening (primary care)
• Be male
• Not have a history of prostate cancer
• Meet one of the following risk criteria:
  • High Risk for Prostate Cancer
    • African American, between the ages of 40 and 75 (inclusive), or
    • Family history of prostate, breast, ovarian, and/or pancreatic cancer, or
    • Known familial germline mutation OR
  • Average Risk for Prostate Cancer
    • Between the ages of 50 and 75 (inclusive)